Idexx Laboratories, Inc.
IDEXX Laboratories Elects New Independent Director
Summary
IDEXX Laboratories, Inc. announced on July 10, 2025, the election of Joseph L. (Jay) Hooley to its Board of Directors as an independent Class III Director, effective July 10, 2025. The Board also appointed him to its Audit Committee and Governance and Corporate Responsibility Committee. With this addition, the Board now consists of ten directors, nine of whom are independent. Mr. Hooley, a former Chair and CEO of State Street Corporation, brings extensive strategic and financial leadership experience to the Board.
Profitelligence Alerts
Get alerts for IDXX
Be first to know when Idexx Laboratories, Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Idexx Laboratories, Inc.
Idexx Laboratories, Inc. is a prominent player in the health technology industry, specializing in veterinary diagnostics, software, and water microbiology testing. The company develops and markets products and services that enhance animal health and well-being, offering a wide range of diagnostic tests for companion animals, livestock, and poultry. It is notably recognized for providing innovative diagnostic services including in-house analyzers and rapid assays, which facilitate quick and accurate diagnostic results for veterinarians. Besides its veterinary focus, Idexx Laboratories also provides water testing solutions aimed at ensuring the safety and quality of water supplies by identifying microbial contaminants. The firm’s advanced diagnostic technologies significantly impact the animal health sector by delivering efficient, reliable diagnostics that enable proactive animal care. Idexx stands out as a key player in enhancing laboratory efficiency through its cloud-based practice management software, improving day-to-day operations for veterinary practices worldwide. Headquartered in Westbrook, Maine, Idexx Laboratories' mission and products underscore its vital role in advancing global animal health and environmental testing solutions, making it a significant entity in the health technology market.
Official SEC Documents
Advertisement